As competition for research funding increases, the ASPIRE program underscores Pfizer's commitment to supporting research in autoimmune diseases within rheumatology and dermatology.
MissionThe mission of the 2014 ASPIRE program is to support basic science, translational and clinical research through a competitive grants program that advances medical knowledge in the epidemiology, pathogenesis and treatment of selected diseases.
The ASPIRE Program demonstrates Pfizer’s commitment to supporting promising investigators with an interest in advancing knowledge in defined disease areas within rheumatology and dermatology.
BackgroundScientific research continues to advance our knowledge and understanding of autoimmune diseases within rheumatology and dermatology. The 2014 ASPIRE Rheumatology and Dermatology Research Awards are designed to fund research proposals aimed to further the understanding of certain autoimmune diseases within rheumatology (rheumatoid arthritis) and dermatology (plaque psoriasis) and contribute to excellence in patient care.
Areas of FocusResearch areas of interest in rheumatoid arthritis and plaque psoriasis are as follows:
- Use of biomarkers in assessment and management of rheumatoid arthritis
- Use of imaging (plain radiography, ultrasound, magnetic resonance imaging) in assessment and management of rheumatoid arthritis
- Comorbid conditions in rheumatoid arthritis (epidemiology, overlapping pathogenesis, assessment and management of these conditions in rheumatoid arthritis patients)
- Approaches to improving adherence to therapy in rheumatoid arthritis patients
- Approaches to improving management of rheumatoid arthritis (e.g. treating to a specific goal or target by monitoring response and adjusting therapy as needed)
- Genomic research to improve understanding of the heterogeneity of plaque psoriasis (for example, differences between “early” onset and “late”onset)
- Signaling pathways implicated in the pathogenesis of plaque psoriasis
- Factors that contribute to differences in physician and patient ratings of severity of plaque psoriasis
- Approaches to improving adherence to therapy in plaque psoriasis patients
- Comorbid conditions in plaque psoriasis (epidemiology, overlapping pathogenesis, assessment and management of these conditions in plaque psoriasis patients)
- Approaches to improving management of plaque psoriasis (e.g. treating to a specific goal or target by monitoring response and adjusting therapy as needed)